In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 11, 2002, Pages 1929-1935

  Jaffer, Farouc A ^a   Tung, Ching Hsuan ^a   Gerszten, Robert E ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Molecular imaging; Near infrared imaging; Optical fluorescence; Thrombin; Thrombosis

Indexed keywords

FLUOROCHROME; THROMBIN;

ARTICLE; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN TISSUE; IMAGING; IN VIVO STUDY; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOGENESIS; THROMBOSIS;

ADULT; ANIMALS; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MOLECULAR PROBES; SPECTROSCOPY, NEAR-INFRARED; THROMBIN; THROMBOSIS;

EID: 0036846990     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000033089.56970.2D     Document Type: Article

References (29)

1. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407:258-264.
2. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I, Bar-Shavit R. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med. 1998;4:909-914.
3. Griffin CT, Srinivasan Y, Zheng YW, Huang W, Coughlin SR. A role for thrombin receptor signaling in endothelial cells during embryonic development. Science. 2001;293:1666-1670.
4. O'Reilly MS, Pirie-Shepherd S, Lane WS, Folkman J. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science. 1999;285:1926-1928.
5. Patterson C, Stouffer GA, Madamanchi N, Runge MS. New tricks for old dogs: Nonthrombotic effects of thrombin in vessel wall biology. Circ Res. 2001;88:987-997.
6. Becker RC, Spencer FA. Thrombin: Structure, biochemistry, measurement, and status in clinical medicine. J Thromb Thrombolysis. 1998;5:215-229.
7. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol. 1999;17:375-378.
8. Tung CH, Mahmood U, Bredow S, Weissleder R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res. 2000;60:4953-4958.
9. Bremer C, Tung CH, Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med. 2001;7:743-748.
10. Mahmood U, Tung CH, Bogdanov A Jr, Weissleder R. Near-infrared optical imaging of protease activity for tumor detection. Radiology. 1999;213:866-870.
11. Ntziachristos V, Ripoll J, Weissleder R. Would near-infrared fluorescence signals propagate through large human organs for clinical studies? Optics Letters. 2002;27:333-335.
12. Ntziachristos V, Tung CH, Bremer C, Weissleder R. Fluorescence-mediated tomography resolves protease activity in vivo. Nat Med. 2002;8:757-761.
13. Tung CH, Gerszten RE, Jaffer FA, Weissleder R. A novel near infrared fluorescence sensor for detection of thrombin activation in blood. Chembiochem. 2002;3:207-211.
14. Rijkers DT, Wielders SJ, Tesser GI, Hemker HC. Design and synthesis of thrombin substrates with modified kinetic parameters. Thromb Res. 1995;79:491-499.
15. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057-1068.
16. Farrehi PM, Ozaki CK, Carmeliet P, Fay WP. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation. 1998;97:1002-1008.
17. Banfield DK, MacGillivray RT. Partial characterization of vertebrate prothrombin cDNAs: Amplification and sequence analysis of the B chain of thrombin from nine different species. Proc Natl Acad Sci U S A. 1992:89:2779-2783.
18. Mattler LE, Bang NU. Serine protease specificity for peptide chromogenic substrates. Thromb Haemost. 1977;38:776-792.
19. Morita T, Kato H, Iwanaga S, Takada K, Kimura T. New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase. J Biochem (Tokyo). 1977;82:1495-1498.
20. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol. 2001;19:316-317.
21. Weissleder R, Mahmood U. Molecular imaging. Radiology. 2001;219:316-333.
22. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandez-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 1997;95:594-599.
23. Moody AR, Pollock JG, O'Connor AR, Bagnall M. Lower-limb deep venous thrombosis: Direct MR imaging of the thrombus. Radiology. 1998;209:349-355.
24. Johnstone MT, Botnar RM, Perez AS, Stewart R, Quist WC, Hamilton JA, Manning WJ. In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol. 2001;21:1556-1560.
25. Corti R, Osende JI, Fayad ZA, Fallon JT, Fuster V, Mizsei G, Dickstein E, Drayer B, Badimon JJ. In vivo noninvasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol. 2002;39:1366-1373.
26. Knight LC. Radiolabeled peptide ligands for imaging thrombi and emboli. Nucl Med Biol. 2001;28:515-526.
27. Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, Sharkey AM, Miller JG, Gaffney PJ, Wickline SA. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation. 1996;94:3334-3340.
28. Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, Lanza GM. Novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques. Circulation. 2001;104:1280-1285.
29. Robinson BR, Houng AK, Reed GL. Catalytic life of activated factor XIII in thrombi: Implications for fibrinolytic resistance and thrombus aging. Circulation. 2000;102:1151-1157.